IAPP and type 2 diabetes mellitus: Human amylin is highly aggregation-prone, and in type-2 diabetes mellitus (T2DM) frequently forms insoluble deposits known as islet amyloid [3]; moreover, potentially pathological deposits of human amylin also occur in the brain in aging and Alzheimer’s disease [4,5].